SOLUPORE
Live / Registered — Registered (as of 01 Dec 2020)
What this means for you
Registered since 01 Dec 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88509550
- Registration number
- 6208574
- Mark type
- Stylized text
- Filed
- 11 Jul 2019
- Published for opposition
- 15 Sept 2020
- Registered
- 01 Dec 2020
- Attorney of record
- Susan Neuberger Weller
Goods and services
- Class 001 — Chemicals: stem cells for research purposes
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, autoimmune disease, rare diseases, viruses, and for use in cell transplantation and engineered cells; stem cells for medical purposes; living cells for medical use
- Class 009 — Scientific and electric apparatus: Scientific apparatus and instruments, namely, scientific apparatus and instruments for the transfer of biological molecules into living cells for the development of cell and gene therapy products; probes for scientific purposes; bioassay apparatus including immune panels; measuring apparatus and instruments, namely, ex-vivo assays for characterization of engineering cells or viruses, other than medical; parts and fittings for the aforesaid goods
- Class 010 — Medical apparatus: Surgical apparatus and instruments, medical apparatus and instruments for the modification of cells for near-patient use; medical apparatus and instruments for the modification of cells for near-patient use; measuring apparatus and instruments for bioassay techniques for medical purposes; parts and fittings for the aforesaid goods
- Class 042 — Scientific and technological services: Scientific and technological services, namely, research and design in the field of process development services for cell and gene therapy products; industrial analysis and research services in the field of cell and gene therapy, and drug delivery; medical, scientific and pharmaceutical research and development, and clinical testing, in the field of pharmaceutical preparations, drugs, cell therapy, gene therapy and cancer therapy; development of probes, reagents and bioassays for industrial and scientific purposes; advisory, consultancy and information services in the fields of biotechnology, pharmaceutical research, laboratory testing, pharmacogenetics, clinical trials, development and genetic science
Owner
- AVECTAS LIMITED, SOUTH DUBLIN 2, IE
- AVECTAS LIMITED, SOUTH DUBLIN 2, IE
- AVECTAS LIMITED, SOUTH DUBLIN 2, IE
Prosecution history
- 01 Dec 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
- 15 Sept 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Sept 2020 — PUBLISHED FOR OPPOSITION
- 26 Aug 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Aug 2020 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 05 Aug 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Aug 2020 — EXAMINER'S AMENDMENT ENTERED
- 05 Aug 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 05 Aug 2020 — EXAMINERS AMENDMENT E-MAILED
- 05 Aug 2020 — EXAMINERS AMENDMENT -WRITTEN
- 27 Jul 2020 — PREVIOUS ALLOWANCE COUNT WITHDRAWN